Breaks Categories: News

MondayApr 28, 2025 10:15 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives. To view the full article, visit https://nnw.fm/bi0fN About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to…

Continue Reading

MondayApr 28, 2025 9:48 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Showcases ADIO® Technology at NFL Alumni Health Draft Week Event

Datavault AI (NASDAQ: DVLT) highlighted its ADIO® tone technology at NFL Alumni Health’s 16th Annual Draft Week event on April 24, 2025, delivering interactive tones synced with top draft picks and geo-targeted health messages across the venue. The platform enabled real-time fan engagement without screens or manual input and supported cardiovascular health awareness for former athletes. Datavault AI’s deployment demonstrated how AI-powered tone technology can deepen audience interaction and create new monetization opportunities at major live events.  To view the full press release, visit https://nnw.fm/w3D52  About Datavault AI Inc.  Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation,…

Continue Reading

MondayApr 28, 2025 9:31 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances RTNova Platform with IL15 Superagonist Payload

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at the AACR Annual Meeting show that Calidi's engineered vaccinia virus can deliver IL15 superagonist directly into the tumor microenvironment, significantly boosting immune response and tumor elimination while minimizing systemic toxicity. The RTNova platform aims to treat metastatic cancers by enabling systemic delivery of tumor-targeted virotherapies.  To view the full press release, visit: https://nnw.fm/m7Yjj  About Calidi Biotherapeutics  Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

Continue Reading

FridayApr 25, 2025 1:40 pm

NetworkNewsBreaks – Newton Golf Company (NASDAQ: NWTG) Gains Momentum on Champions Tour with Golf.com Spotlight

Newton Golf Company Inc. (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design, has seen its Newton Motion shafts rapidly gain popularity on the Champions Tour, recently earning a feature on Golf.com for their innovative performance benefits tailored to senior players. The shafts utilize a unique variable stiffness profile—more flexible in the midsection and stiffer at the tip and butt ends—resulting in improved energy transfer, higher launch angles, and increased distance. These design advantages have made them a go-to choice for many veteran professionals seeking more consistency and power in their drives.  To read…

Continue Reading

FridayApr 25, 2025 10:30 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2025 Financial Results on May 8

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software, and services, will release its first-quarter fiscal 2025 results before market open on Thursday, May 8, 2025. D-Wave will host a conference call featuring CEO Dr. Alan Baratz and CFO John Markovich at 8:00 a.m. ET that day to discuss financial results and business outlook. The earnings press release and webcast replay will be available on the D-Wave Investor Relations website. To view the full press release, visit https://nnw.fm/GMcLc. About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing…

Continue Reading

FridayApr 25, 2025 9:51 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Grants Inducement Stock Option to New CEO Eric Poma

Calidi Biotherapeutics (NYSE American: CLDI) a clinical-stage biotechnology company advancing targeted antitumor virotherapies, announced the approval of an inducement non-qualified stock option grant to new Chief Executive Officer Eric Poma, Ph.D. The grant includes the option to purchase 726,412 shares at an exercise price of $0.469, the closing price of Calidi’s common stock on April 22, 2025. The options will vest over four years, with 25% vesting on April 22, 2026, and the remainder vesting in equal monthly installments through April 22, 2029, in accordance with Section 711 of the NYSE American LLC Company Guide.  To view the full press…

Continue Reading

FridayApr 25, 2025 9:00 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in Benzinga Video Highlighting 75% HyBryte™ Response Rate in FDA-Backed Skin Cancer Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, is featured in a new Benzinga video detailing clinical progress for its lead candidate HyBryte™, which achieved a 75% response rate in a trial for cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer. The trial is supported by funding from a U.S. Food and Drug Administration’s Orphan Products Development Grant and showcases HyBryte’s™ potential as a first-in-class, light-activated, non-invasive therapy. HyBryte™ is a first-in-class photodynamic therapy activated by safe visible light and has previously received Orphan Drug and Fast Track designations. Soligenix plans to continue advancing regulatory…

Continue Reading

ThursdayApr 24, 2025 2:13 pm

NetworkNewsBreaks – InnerScope Hearing Technologies (INND) Expands Footprint with Launch of OTCHealthMart.com 

InnerScope (OTC: INND) today announced the official grand opening of OTCHealthMart.com, a cutting-edge online platform designed to make healthcare products accessible and affordable for everyone. The new platform offers a comprehensive range of over-the-counter (“OTC”) health and wellness products, including premium and affordable OTC hearing aids powered by HearingAssist and iHEAR brand labels, a specialty line of vitamins and health supplements specifically designed for the 55+ demographic, and plans to expand offerings to include durable medical equipment (“DME”) in its next phase.  "We are thrilled to launch OTCHealthMart.com, making quality healthcare products accessible to everyone," said Matthew Moore, CEO of…

Continue Reading

ThursdayApr 24, 2025 1:33 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Advances U.S. Quantum Infrastructure with Davidson Installation Milestone 

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced the completion of physical assembly for its Advantage2TM annealing quantum system at Davidson Technologies’ headquarters in Huntsville, Alabama. The system, the first of its kind hosted on-premises in the state, is entering final calibration and testing ahead of operational deployment. Developed in partnership with Davidson, the companies believe that the installation marks a pivotal step in advancing secure quantum computing capabilities for U.S. Department of Defense applications. A private ribbon-cutting ceremony was held on April 23 to commemorate the milestone. The system is intended to support mission-critical quantum optimization efforts in areas such…

Continue Reading

ThursdayApr 24, 2025 12:25 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Confirms Major Untested VMS Target at Montauban Following VTEM Data Review 

ESGold (CSE: ESAU) (OTCQB: ESAUF) has identified a large-scale, high-conductivity geophysical anomaly in the southwestern portion of its Montauban Project following an internal review of its 2015 VTEM survey and historical drill data. This zone, now fully enclosed within ESGold’s expanded 255-claim package totaling 13,116 hectares, remains undrilled and is considered a high-priority target due to its strong conductive and magnetic signature, typical of buried sulfide-rich VMS environments. The Company is finalizing the first-ever 3D geological model of the project, integrating VTEM and TMI data, over 950 historical drillholes, and upcoming ANT survey results to guide future drilling. While ESGold…

Continue Reading